A2 Bio Receives FDA Orphan Drug Designation for Novel Cell Therapy Program A2B530 in Colorectal Cancer
Novel investigational cell therapy A2B530 currently being evaluated in EVEREST-1 Phase 1 trial granted Orphan Drug Designation for the treatment of germline heterozygous... Read more.
BILL Survey Finds 85% of SMBs Are Enthusiastic About Using AI in Financial Operations
Businesses view AI as a beneficial tool for both strategic planning and everyday operations SAN JOSE, Calif.–(BUSINESS WIRE)–BILL (NYSE: BILL), a leading... Read more.
Global Alternative Online Payment Methods 2024 – Digital Wallets are Among the Most Popular Digital Payment Methods Globally – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Alternative Online Payment Methods 2024” report has been added to ResearchAndMarkets.com’s offering.... Read more.
Q-nomy Announces the Launch of Q-Flow Online Booking Journey: A Leap into Next-Generation Customer Engagement Solutions
The Online Booking Journey adds customizable, easily integrated booking capabilities to Q‑nomy’s Q‑Flow® software platform. MIAMI–(BUSINESS WIRE)–#AppointmentBooking–Q-nomy... Read more.
Printed and Flexible Electronics Global Outlook 2024-2034: Historic Revenues from 2018-2022 and Market Forecasts to 2034, By Technology, Components, Products, Regions and Application Sector – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Market for Printed and Flexible Electronics 2024-2034” report has been added to ResearchAndMarkets.com’s... Read more.
Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024” report has been added to... Read more.
Cadre Holdings Completes Acquisition of Alpha Safety
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Cadre Holdings, Inc. (NYSE: CDRE) (“Cadre” or “the Company”), a global leader in the manufacturing and distribution... Read more.
Sarepta Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced... Read more.
Volato Announces Participation in Upcoming Conferences
ATLANTA–(BUSINESS WIRE)–Volato Group, Inc. (NYSE American: SOAR) (“Volato”), a leading private aviation company and the largest HondaJet operator... Read more.
Cyolo Announces Cyolo PRO: A Hybrid Secure Remote Access Solution for OT Environments
Cyolo PRO delivers safe and privileged remote operations, redefining the SRA and RPAM markets MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Cyolo, the access... Read more.